Journal of Pharmaceutical Sciences p. 1585 - 1587 (1984)
Update date:2022-08-03
Topics:
Crider
Hemdi
Hassan
Fahn
3-(3,4-Dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide was synthesized by a six-step reaction sequence and was evaluated, and compared with apomarphine, for central dopaminergic agonist activity. The compound produced behavioral and biochemical change
View MoreChangyi Xinxing Technology Development Co., Ltd.
Contact:0086-510-86651065(Time Zone:8),86651656
Address:94 Yingbinxilu WestRoad, Huangtu Town, Jiangyin City, Jiangsu, China
Tangshan Wisdom Trading Co.,Ltd
Contact:86 315 2222979
Address:No.41 BeiXinXi Road, Yangguang building 1-1102 , Tangshan, Hebei, China
Shanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd
Contact:+86-0372-3662335 +86-0372-3661988
Address:hanling industrial park anyang
Suzhou Health Chemicals Co., Ltd.
website:http://www.healthchems.com
Contact:13776257979
Address:No. 338, Jingang Avenue,
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Doi:10.1002/ejic.200600710
(2007)Doi:10.1016/j.tet.2010.08.050
(2010)Doi:10.1016/S0040-4020(01)96900-5
(1984)Doi:10.1039/c2dt30512g
(2012)Doi:10.1039/b919120h
(2010)Doi:10.1016/j.chembiol.2019.03.016
(2019)
